Specific features of the diagnosis and treatment of community-acquired pneumonia in pregnant women

DOI: https://doi.org/10.29296/25877305-2018-08-02
Download full text PDF
Issue: 
8
Year: 
2018

Professor O. Lavrova, MD; Professor M. Petrova, MD I.P. Pavlov First Saint Petersburg State Medical University

The diagnosis of community-acquired pneumonia and the choice of adequate therapy during pregnancy have a number of features. This is due to both clinical features and certain restrictions on the prescription of antibacterial drugs, some groups of which may have a negative effect on a fetus.

Keywords: 
obstetrics and gynecology
pregnancy
community-acquired pneumonia
treatment



It appears your Web browser is not configured to display PDF files. Download adobe Acrobat или click here to download the PDF file.

References: 
  1. in A.G. i soavt. Vnebol'nichnaja pnevmonija u vzroslyh: prakticheskie rekomendatsii po diagnostike, lecheniju i profilaktike // Klin. mikrobiol. antimikrob. himioter. – 2006; 8 (1): 54–86.
  2. Vnebol'nichnaja pnevmonija. Klinicheskie rekomendatsii / Rossijskoe respiratornoe obschestvo, 2018. spulmo.ru
  3. Jin Y., Carriere K., Marrie T. et al. The effects of community-acquired pneumonia during pregnancy ending in a live birth // Am. J. Obstet. Gynecol. – 2003; 18: 800–6.
  4. Goodnight W., Soper D. Pneumonia in pregnancy // Crit. Care Med. – 2005; 33 (10 Suppl) : 390–7.
  5. Panting-Kemp A., Geller S., Nguyen T. et al. Maternal deaths in an urban perinatal network, 1992–1998 // Am. J. Obstet. Gynecol. – 2000; 183: 1207–12.
  6. Lim W., Macfarlane J., Colthorpe C. Treatmentof community-acquired lower respiratory tract infections during pregnancy // Am. J. Respir. Med. – 2003; 2: 221–33.
  7. Mehta N., Chen K., Hardy E. et al. Pneumonia in pregnancy // Best Pract. Res. Clin. Obstet. Gynaecol. – 2015; 29 (5): 598–611.
  8. Madinger N., Greenspoon J., Ellrodt A. Pneumonia during pregnancy: Has modern technology improved maternal and fetal outcome? // Am. J. Obstet. Gynecol. – 1989; 161: 657–62.
  9. Sinopal'nikov A.I., Fesenko O.V. Vnebol'nichnaja pnevmonija / M.: GEOTAR-Media, 2017; 112 s.
  10. Tan E.K., Tan E.L. Alterations in physiology and anatomy during pregnancy // Best Pract. Res. Clin. Obstet. Gynaecol. – 2013; 27: 791–802.
  11. Brito V., Niederman M. Pneumonia complicating pregnancy // Clin. Chest Med. – 2011; 32: 121–32.
  12. Romanyuk V., Raichel L., Sergienko R. et al. Pneumonia during pregnancy: radiological characteristics, predisposing factors and pregnancy outcomes // J. Matern. Fetal. Neonatal. Med. – 2011; 24 (1): 113–7.
  13. Ie S., Rubio E., Alper B. et al. Respiratory complications of pregnancy // Obstet. Gynecol. Surv. – 2001; 57: 39–46.
  14. Wacker E., Navarro A., Meister R. et al. Does the average drug exposure in pregnant women affect pregnancy outcome? A comparison of two approaches to estimate the baseline risks of adverse pregnancy outcome // Pharmacoepidemiol. Drug Saf. – 2015; 24 (4): 353–60.
  15. Berkovitch M., Diav-Citrin O., Greenberg R. et al. First-trimester exposure to amoxycillin/clavulanic acid: a prospective, controlled study // Br. J. Clin. Pharmacol. – 2004; 58 (3): 298–302.
  16. Czeizel A., Rockenbauer M., Sørensen H. et al. Augmentin treatment during pregnancy and the prevalence of congenital abnormalities: a population-based case-control teratologic study // Eur. J. Obstet. Gynecol. Reprod. Biol. – 2001; 97 (2): 188–92.
  17. Lin K., Mitchell A., Yau W. et al. Safety of macrolides during pregnancy // Am. J. Obstet. Gynecol. – 2013; 208 (3): 221.e1–8. DOI: 10.1016/j.ajog.2012.12.023.
  18. Padberg S., Wacker E., Meister R. et al. Observational cohort study of pregnancy outcome after first-trimester exposure to fluoroquinolones // Antimicrob. Agents Chemother. – 2014; 58 (8): 4392–8. DOI: 10.1128/AAC.02413-14.